Skip to main content
Equibles
INNV logo

INNV · InnovAge Holding Corp. · Metrics

Track INNV — free

Use INNV with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research INNV.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$9.55 +0.03 (+0.32%) At close · Oct 23
Russell 2000 member Rebalance outlook locked
Market Cap
$1.30B
Shares
136.45M
Volume · Oct 23 460.87K Avg daily vol (3M) 500.95K

INNV metrics

96 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$9.55
Market cap
$1.30B

Price action

20 metrics
Price change (1W)
+7.9%
Price change (30D)
+6.1%
Price change (3M)
-17.4%
Price change (6M)
+20.1%
Price change (YTD)
+84.0%
Price change (1Y)
+83.0%
Trailing year
Price change (5Y)
+41.9%
52-week high
$12.11
52-week low
$3.99
Change from 52-week high
-21.1%
Change from 52-week low
+139.3%
Annualized volatility
75.3%
Annualized volatility (3M)
44.1%
Beta
0.5
RSI (14D)
53.7
Price vs SMA 50
-4.5%
Price vs SMA 200
+6.4%
Avg volume (3M)
500,951
Relative volume
0.9
Average dollar volume
$4.82M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
136.45M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
1.2×
reciprocal yield 81.8%
EV / EBITDA
50.9×
reciprocal yield 2.0%
EV / EBIT
462.1×
reciprocal yield 0.2%
P / sales
1.3×
reciprocal yield 75.9%
P / book
5.5
reciprocal yield 18.1%
FCF yield
3.9%
TTM · current market cap
Buyback yield
6.0%
P / FCF
25.9
reciprocal yield 3.9%
P / operating cash flow
20.1
reciprocal yield 5.0%
Earnings yield
-0.2%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
0.9×
reciprocal yield 114.1%
EV / revenue historical average (5Y)
0.9×
reciprocal yield 108.2%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
138.6×
reciprocal yield 0.7%
EV / EBITDA historical average (3Y)
144.3×
reciprocal yield 0.7%
EV / EBITDA historical average (5Y)
90.8×
reciprocal yield 1.1%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
6.7%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-03
Last earnings
2026-09-08

Profitability

9 metrics
Gross margin
23.0%
Operating margin
0.3%
Trailing 12 months
Net margin
-0.3%
Gross profit (TTM)
$227.76M
Operating profit (TTM)
$2.62M
Net income (TTM)
−$2.54M
Trailing 12 months
Diluted EPS (TTM)
$-0.02
FCF margin
5.1%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$7.30
Gross profit per diluted share (TTM)
$1.68
Operating profit per diluted share (TTM)
$0.02
EBITDA per diluted share (TTM)
$0.18
Net income per diluted share (TTM)
$-0.02
Operating cash flow per diluted share (TTM)
$0.48
Free cash flow per diluted share (TTM)
$0.37
Capital expenditures per diluted share (TTM)
$0.11
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.05
Book value per share
$1.73

Growth

11 metrics
Revenue growth YoY
+18.3%
Year over year
Net income growth YoY
—
Revenue (TTM)
$989.71M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.4%
Year over year · more shares
Revenue CAGR (3Y)
+12.9%
Revenue CAGR (5Y)
+9.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-1.1%
Return on assets
-0.5%
Debt / equity
0.2
Current ratio
1.1
EBITDA (TTM)
$23.76M
Free cash flow (TTM)
$50.41M
Quick ratio
1.1
Interest coverage
—
Net debt / EBITDA
-3.9
Return on invested capital
—
Trailing 12 months
Net cash
$93.27M
Latest balance sheet
Cash & equivalents
$97.89M
Total assets
$557.39M
Total debt
$48.06M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$64.71M
Capital expenditures (TTM)
$14.31M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$7.05M
R&D / revenue
—
Stock compensation / revenue
0.7%

Ownership (13F)

9 metrics
13F filers
107
13F filer change QoQ
+3
Institutional ownership
13.5%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
2.9%
Private-fund adviser ownership
2.8%
Active holders' share change QoQ
+18.9%
Holder tenure
10.1
Price vs estimated holder cost
+19.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
2.2%

Short interest

3 metrics
Short interest
2.0%
Latest settlement · 2.4 days to cover
Days to cover
2.4d
Short-squeeze score
49 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$207,182
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1834376 CUSIP 45784A104 13F (30d) 14 filings 14 filers Visit website Investor relations